ARE vs TSHA · P/E 100, rev $662.8M vs $640.7M cap
Alexandria Real Estate Equities Inc (ARE) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported ARE revenue for 2026-06-30 was $662.8M. Net income was -$72.8M. Revenue was down 1.2% from 2026-03-31 to 2026-06-30. ARE currently screens at market cap $13.19B and trailing P/E 100.4.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
ARE currently screens at market cap $13.19B and trailing P/E 100.4. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the ARE and TSHA stock pages for the full models.
Not investment advice.